Clinical Trials Logo

Spondylitis clinical trials

View clinical trials related to Spondylitis.

Filter by:

NCT ID: NCT04507763 Completed - Clinical trials for Ankylosing Spondylitis

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Start date: August 1, 2020
Phase:
Study type: Observational

This study is to evaluate available data in Iraqi patients with ankylosing spondylitis on Enbrel treatment with regards to the impact of early treatment using data from the Baghdad Teaching Hospital registry

NCT ID: NCT04507659 Completed - Clinical trials for Ankylosing Spondylitis

Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis

AS
Start date: December 1, 2020
Phase: Phase 2
Study type: Interventional

This trial uses a multi-center, randomized, double-blind, placebo, parallel-controlled design, and it is expected that about 105 cases will be enrolled in about 10 sites.

NCT ID: NCT04489342 Recruiting - Clinical trials for Axial Spondyloarthritis

Advanced Sensor Based Functional ASsessmenTs in Axial Spondyloarthritis

ASFASTAS
Start date: July 1, 2019
Phase:
Study type: Observational

This is an observational study using Inertial Measurement Unit (IMU) sensors to measure the effects of biological therapy on spinal mobility and function in axial spondyloarthritis. Participants will undergo MRI scans before and after therapy in parallel to the sensor tests to establish correlation between changes in inflammatory signs and changes in spinal mobility.

NCT ID: NCT04483700 Withdrawn - Clinical trials for Ankylosing Spondylitis

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy

SEALION2-NAÏVE
Start date: December 2020
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the effect of filgotinib versus placebo on signs and symptoms of active ankylosing spondylitis (AS), evaluated by Assessment of SpondyloArthritis international Society 40% improvement (ASAS40) response at Week 16 in participants with active AS who are naive to biologic disease-modifying antirheumatic drug therapy.

NCT ID: NCT04483687 Withdrawn - Clinical trials for Ankylosing Spondylitis

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy

SEALION1-IR
Start date: December 2020
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the effect of filgotinib versus placebo on signs and symptoms of active ankylosing spondylitis (AS), evaluated by Assessment of SpondyloArthritis international Society 40% improvement (ASAS40) response at Week 16 in participants with active AS who have an inadequate response to biologic disease-modifying antirheumatic drug therapy.

NCT ID: NCT04483648 Completed - Spondyloarthritis Clinical Trials

Cervical Stabilization Exercises in Patients With Spondyloarthritis

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effectiveness of cervical stabilization exercises on cervical positioning error in spondyloarthritis patients.

NCT ID: NCT04481139 Completed - Clinical trials for Ankylosing Spondylitis

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis

Start date: October 14, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

This study is to evaluate the efficacy and safety of different doses of JAK1 inhibitor SHR0302 in subjects with active ankylosing spondylitis.

NCT ID: NCT04480359 Recruiting - Clinical trials for Ankylosing Spondylitis

Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis

Start date: October 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether Bawei Shenqi Pill is effective in the treatment of active ankylosing spondylitis (AS).

NCT ID: NCT04451681 Completed - Clinical trials for Ankylosing Spondylitis

Evaluation of Physical Performance in Ankylosing Spondylitis Patients

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Ankylosing spondylitis (AS) can cause serious limitations in individuals' physical performance, as it involves the musculoskeletal system and can cause ankylosis and arthritis in both axial and peripheral joints. Although there are many studies showing these limitations nowadays, there is a need to show these limitations with more objective data with the new technology. Evaluating aerobic physical capacity; Cardiopulmonary Exercise Test (KPET) is frequently used in physical performance analysis today. In this study, the investigators want to observe the physical performance differences between 42 AS patients and 42 control group participants by applying KPET and present the expected performance losses in AS patients in the literature with objective data.

NCT ID: NCT04437394 Completed - Clinical trials for Ankylosing Spondylitis

Evaluation of Functions of Swallowing and Voice in Ankylosing Spondylitis Patients

Start date: June 30, 2018
Phase:
Study type: Observational

In this study was to determine whether changes that occurred over time had an impact on the swallowing and voice functions depend of Ankylosing spondylitis patients.